Translational and pharmacological principles of hyperthermic intraperitoneal chemotherapy for ovarian cancer
Volume: 78, Pages: 86 - 102
Published: Jan 1, 2022
Abstract
The long-term survival of advanced-stage ovarian cancer patients remains poor, despite extensive cytoreductive surgery, chemotherapy, and the recent addition of poly (ADP-ribose) polymerase inhibitors (PARPi). Hyperthermic intraperitoneal chemotherapy (HIPEC) has shown survival benefit by specifically targeting peritoneal metastases, the primary site of disease recurrence. Different aspects of how HIPEC exerts its effect remain poorly...
Paper Details
Title
Translational and pharmacological principles of hyperthermic intraperitoneal chemotherapy for ovarian cancer
Published Date
Jan 1, 2022
Volume
78
Pages
86 - 102
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History